Hatch Amendment Would Offer Generic Litigants Patent Appeal Choice

Sen. Orrin Hatch (R-Utah) proposes to amend the landmark Hatch-Waxman Act to require generic drugmakers challenging brand patents to choose between inter partes reviews or Hatch-Waxman litigation.
Source: Drug Industry Daily